Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine

Messoud Ashina, Peter J. Goadsby, Uwe Reuter, Stephen Silberstein, David Dodick, Gregory A. Rippon, Jan Klatt, Fei Xue, Victoria Chia, Feng Zhang, Sunfa Cheng, Daniel D. Mikol

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine'. Together they form a unique fingerprint.

Medicine & Life Sciences